It seems the content is not visible or provided. Please share the content you'd like summarized, and I'd be happy to help!
NVS has been in the news recently: Novartis AG reported first-quarter 2025 adjusted earnings per share of $2.28, exceeding expectations of $2.10, and announced its plan to acquire Regulus Therapeutics for $7.00 per share, totaling approximately $1.7 billion. The acquisition is expected to be completed in the second half of 2025.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.